sinn95_ Thomas LohnesGetty Images_biontech Thomas Lohnes/Getty Images

Successful Immigration and the New German Vaccine

BioNTech's new-model RNA-based vaccine has emerged as the leading contender to bring an end to the COVID-19 pandemic, possibly within the coming year. Pioneered by a Turkish-German couple whose parents immigrated to Germany in the 1960s, the breakthrough's symbolic importance matches its practical value.

MUNICH – The world took note when the German start-up BioNTech announced its breakthrough in the development of a new type of vaccine to combat COVID-19. After testing tens of thousands of people, BioNTech’s vaccine has been shown to be 95% effective in providing protection for those who would otherwise have been infected. The company was the first to apply for emergency use authorization for a coronavirus vaccine in the United States, and it has announced that it will soon take similar steps in Europe.

https://prosyn.org/Fkxgiu2